The biopharmaceutical company announced that CEO Leen Kawas has resigned from the company after an internal investigation found she had altered images in her doctoral dissertation and "at least four research papers" written while she was at WSU.
source https://www.seattletimes.com/business/athira-pharma-ceo-resigns-after-internal-investigation-finds-research-malpractice/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology
No comments:
Post a Comment